Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in Parkinson's disease model mice
pubmed.ncbi.nlm.nih.gov/351...
Dexmedetomidine (DEX) is a sedative and analgesic drug.
Dexmedetomidine attenuates motor deficits... - Cure Parkinson's
Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in Parkinson's disease - mice
Read more about...
2 Replies
•
from 2015
pubmed.ncbi.nlm.nih.gov/266...
Factors Associated with Tremor Changes during Sedation with Dexmedetomidine in Parkinson's Disease Surgery
Abstract
Introduction: Dexmedetomidine is an α2-agonist recently proposed as a potentially ideal drug for sedation during the surgical treatment of Parkinson's disease (PD). This report documents the incidence of changes in motor symptoms (especially tremor) in PD patients sedated with dexmedetomidine for deep brain stimulation or ablation procedures.
Methods: We reviewed a retrospective cohort of 22 patients who underwent surgery for PD with dexmedetomidine sedation at a single institution from 2010 to 2014. A logistic regression analysis was performed to analyze possible confounding factors.
Results: 14 cases of tremor reduction or suppression were recorded (cumulative incidence: 63.6%; 95% CI: 40.7-82.8). No association could be identified between loading dose, β-blocker use and preoperative total Unified Parkinson's Disease Rating Scale III, with tremor changes. The maintenance dose of dexmedetomidine was higher in patients who did not experience changes [median and range for patients with and without tremor alteration 0.75 (0.2-1.0) and 1.0 µg × kg(-1) × h(-1) (0.7-1.4), respectively; p = 0.021].
Conclusion: Dexmedetomidine provides adequate sedation during surgery for PD, but it might affect motor signs making intraoperative testing difficult or even impossible. Dosage appears not to be the determining factor in motor changes, whose cause remains unclear.
thank you for the post... seems like 'everything works on mice' but when it gets to testing on 'humans'........ not so much, boo hoo
Not what you're looking for?
You may also like...
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
with experience of using Gastrodin or Tian Ma?
https://bmcneurosci.biomedcentral.com/articles/10.118
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
causal in many serious diseases such as ALS/MND, Parkinson’s Disease, Alzheimer’s disease, MS, etc....
